ArticleScientific reports2025
Genomic epidemiology of Mycobacterium tuberculosis in Wales.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Identification of factors contributing to tuberculosis (TB) transmission can guide targeted measures to reduce morbidity. Varying findings for factors associated with TB genomic clustering exist. We describe Mycobacterium tuberculosis strain diversity, drug-resistance, and ongoing transmission in Wales using single nucleotide polymorphisms (SNP)-based typing to infer lineage and clusters. TB cohort data on isolates from Welsh residents from 2012 to 2022, patient level data from the National TB Surveillance System and SNP-based data, were merged. Descriptive epidemiology and logistic regression modelling were used to identify factors associated with genotypic clustering. 215 cases were included in the cluster analysis (66% male and 46% born outside of the UK); 115/215 belonged to 30 genomic clusters belonging to lineages 2-4. Most clusters corresponded to Lineage 4 and were distributed within South Wales. There were significant differences in the distribution of ethnicity, age group, and deprivation (Welsh Index of Multiple Deprivation, WIMD) in our sample compared to the Welsh population. Resistance to rifampicin and isoniazid and predicted resistance to ethambutol, aminoglycosides, pyrazinamide, and quinolone was low. Factors associated with increased odds of clustering included being UK-born and having pulmonary disease. Due to the identification of the above factors associated with TB genomic clustering, as well as the differences in ethnicity, age group, and WIMD quintile, prevention strategies for TB screening targeted towards these groups may be considered. Future work may evaluate the utility of additional control measures within these populations when the onset case in a genomic cluster has any of these characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.